SCHEMBL2710083

SCHEMBL2710083

O=c1[nH]c(-c2ccccc2C(F)(F)F)cc2ccc(NC(O)=S)cc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.42
PDE10A Q9Y233 1/20 0.41
KIT P10721 1/20 0.39
C1R P00736 1/20 0.39
PTPRC P08575 1/20 0.38
PIK3C3 Q8NEB9 2/20 0.37
STK10 O94804 2/20 0.36
SLK Q9H2G2 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GAA P10253 2/20 0.36
MEN1 O00255 1/20 0.36
GLA P06280 1/20 0.36
HPGD P15428 1/20 0.36
KMT2A Q03164 1/20 0.36
BRD4 O60885 2/20 0.36
ABL1 P00519 1/20 0.35
EPHX1 P07099 1/20 0.35
ACP1 P24666 1/20 0.35
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2709079 0.90 FFAR1 (0.45) FFAR1PDE10AKITC1RPTPRC
SCHEMBL824756 0.87 BRD4 (0.51) FFAR1KITPTPRCMEN1KMT2A
SCHEMBL2710082 0.87 FFAR1 (0.42) FFAR1PDE10AKITC1RPTPRC
SCHEMBL824754 0.85 KIT (0.42) FFAR1PDE10AKITPTPRCPIK3C3
SCHEMBL3543216 0.84 PARP1 (0.45) FFAR1PDE10AKITPTPRCABL1
SCHEMBL824963 0.84 AR (0.45) FFAR1PDE10AKITC1RPIK3C3
SCHEMBL824921 0.82 FFAR1 (0.42) FFAR1PDE10AKITC1RSTK10
SCHEMBL824707 0.82 ROCK2 (0.53) FFAR1ALDH1A1MAPTPOLB
SCHEMBL824692 0.81 KCNJ11 (0.42) FFAR1PDE10AKITPTPRCPIK3C3
SCHEMBL824729 0.81 FFAR1 (0.40) FFAR1PDE10AKITPTPRCPIK3C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1724262-B1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI PHARMACEUTICAL CO LTD (JP) 2012-05-02 EP disclosed
US-20070185160-A1 1-(2H)-isoquinolone derivative CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2007-08-09 US disclosed
EP-1724262-A1 1-(2H)-ISOQUINOLONE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2006-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185160-A1 1-(2H)-isoquinolone derivative NR3C2, NR1H4, NR3C1 FFAR1 452/4885PDE10A 3212/4885KIT 4832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.